Literature DB >> 11554439

Chemical enhancers for transdermal drug transport.

K Bauerová1, D Matusová, Z Kassai.   

Abstract

In its first part, this review paper discusses skin morphology and barrier function of the stratum corneum for drug permeation after its transdermal administration or topical application. Further, the paper presents the main methods for overcoming the skin permeation barrier, which plays an important role for transdermal drug administration. Focus is on the method of chemical permeation enhancement. The chemical enhancers are categorised by their chemical structure. Examples of the most effective enhancers are given for the chemical groups of alcohols, amines and amides, polyalcohols, terpenes, fatty acids and their esters, macro cyclic compounds, sulfoxides, tensides, and others, as e.g. soft enhancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11554439     DOI: 10.1007/BF03190381

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  86 in total

1.  Effect of pyrrolidone derivatives on lipid membrane and protein conformation as transdermal penetration enhancer.

Authors:  H Sasaki; M Kishikawa; J Nakamura; J Shibasaki
Journal:  J Pharmacobiodyn       Date:  1990-08

2.  Evidence that oleic acid exists in a separate phase within stratum corneum lipids.

Authors:  B Ongpipattanakul; R R Burnette; R O Potts; M L Francoeur
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 3.  Transdermal drug delivery: problems and possibilities.

Authors:  V M Knepp; J Hadgraft; R H Guy
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

4.  Influence of limonene and laurocapram on percutaneous absorption of nonsteroidal anti-inflammatory drugs.

Authors:  J Priborský; K Takayama; Y Obata; Z Príborská; T Nagai
Journal:  Arzneimittelforschung       Date:  1992-02

5.  Immunomodulation of psoriasis with a topical cyclosporin A formulation.

Authors:  J I Duncan; R A Wakeel; A J Winfield; A D Ormerod; A W Thomson
Journal:  Acta Derm Venereol       Date:  1993-04       Impact factor: 4.437

6.  Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.

Authors:  K Uekama; H Adachi; T Irie; T Yano; M Saita; K Noda
Journal:  J Pharm Pharmacol       Date:  1992-02       Impact factor: 3.765

7.  In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum.

Authors:  F Yamashita; H Bando; Y Koyama; S Kitagawa; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

8.  Influence of irritants on lymph node cell proliferation and the detection of contact sensitivity to metal salts in the murine local lymph node assay.

Authors:  Y Ikarashi; Y Tsukamoto; T Tsuchiya; A Nakamura
Journal:  Contact Dermatitis       Date:  1993-09       Impact factor: 6.600

9.  Percutaneous penetration of acyclovir through excised hairless mouse and rat skin: effect of vehicle and percutaneous penetration enhancer.

Authors:  H Okamoto; K Muta; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

10.  Effect of hydrophilic and lipophilic vehicles on skin permeation of tegafur, alclofenac and ibuprofen with or without permeation enhancers.

Authors:  C K Lee; T Uchida; K Kitagawa; A Yagi; N S Kim; S Goto
Journal:  Biol Pharm Bull       Date:  1993-12       Impact factor: 2.233

View more
  6 in total

1.  Design principles of chemical penetration enhancers for transdermal drug delivery.

Authors:  Pankaj Karande; Amit Jain; Kaitlin Ergun; Vincent Kispersky; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

2.  A microscopic multiphase diffusion model of viable epidermis permeability.

Authors:  Johannes M Nitsche; Gerald B Kasting
Journal:  Biophys J       Date:  2013-05-21       Impact factor: 4.033

3.  Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.

Authors:  Marilyn Cost; Charlene S Dezzutti; Meredith R Clark; David R Friend; Ayman Akil; Lisa Cencia Rohan
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

4.  Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.

Authors:  Mikolaj Milewski; Kalpana S Paudel; Nicole K Brogden; Priyanka Ghosh; Stan L Banks; Dana C Hammell; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

5.  Formulations for trans-tympanic antibiotic delivery.

Authors:  Xiaojuan Khoo; Emmanuel J Simons; Homer H Chiang; Julia M Hickey; Vishakha Sabharwal; Stephen I Pelton; John J Rosowski; Robert Langer; Daniel S Kohane
Journal:  Biomaterials       Date:  2012-11-09       Impact factor: 12.479

6.  Effect of chemical permeation enhancers on nerve blockade.

Authors:  Emmanuel J Simons; Evangelia Bellas; Michael W Lawlor; Daniel S Kohane
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.